CXCL12 and ST Elevation Myocardial Infarction: Percentage of circulatory platelet-progenitor cell aggregates is significantly enhanced in ACS, particularly in patients with ST-elevation myocardial infarction (STEMI), who also exhibit a CXCL12/SDF1α enriched platelet surface.